Domainex and Ark Therapeutics Extend Drug Discovery Agreement
News Jul 09, 2009
Domainex Ltd has announced an extension of its research agreement with Ark Therapeutics Group Ltd (Ark). Under the terms of the agreement Domainex will continue to provide Ark with hit-finding and lead optimization services for drug discovery against novel and exciting therapeutic targets nominated by the company.
Domainex and Ark have been working closely together for several years, successfully combining Domainex’s capabilities in drug design and lead optimization with Ark’s disease and molecular biology expertise.
Domainex’s experienced research team specialize in the provision of medicinal chemistry, computer-aided drug design, biochemistry, and molecular biology services which are tailored to the specific needs of biotechnology companies and academic research groups. The company is also developing its own pipeline of pre-clinical drugs and targets.
Dr Trevor Perrior, Research Director of Domainex, commented: “Domainex is delighted that Ark has decided to extend our productive relationship. The synergy and teamwork between our respective scientists have been outstanding, and this collaboration has already resulted in the achievement of key breakthroughs against very challenging scientific goals.”
Dr. Perrior continued, “We look forward to taking these programmes to the next stage of their development, with the aim of delivering important new treatments for major life-threatening diseases. The renewal of this contract is a further illustration of the value that clients such as Ark place on the contribution that Domainex is able to bring to their drug research programmes.”
Computer bits are binary, with a value of 0 or 1. By contrast, neurons in the brain can have all kinds of different internal states, depending on the input that they received. This allows the brain to process information in a more energy-efficient manner than a computer. A new study hopes to bring the two closer together.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Feb 27 - Feb 28, 2019
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
14th World Congress on Medicinal Chemistry and Drug Design
Jun 10 - Jun 11, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019